Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-25 @ 2:46 AM
NCT ID:
NCT04785833
Eligibility Criteria:
Inclusion Criteria:
* Age 12-65
* Sign informed consent
* Expected survival time ≥ 3 months
* CD7 positive refractory and relapsed acute leukemia
* Karnofsky score≥60
* ECOG score ≤ 2
* Have not received other immunotherapy within 3 months
* The CD7 expression rate on the surface of leukemia cells detected by flow cytometry is greater than 30%
Exclusion Criteria:
* Uncontrolled active infection
* Active viral hepatitis B or C
* HIV test positive
* Congenital immunodeficiency patients
* Pregnant and breastfeeding patients
* Patients with central nervous system tumors or central nervous system leukemia
* The patient and/or family members do not agree to the treatment plan
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
65 Years
Study:
NCT04785833
Study Brief:
Protocol Section:
NCT04785833